Currently, out of the existing stock ratings of Josh Schimmer - 37 which are a Buy (97.37%), 1 which are a Hold (2.63%)

Josh Schimmer

Work Performance Price Targets & Ratings Chart

Analyst Josh Schimmer works at EVERCORE and is covering the Healthcare sector with 444 price targets and ratings displayed on 16 stocks. Previously, Josh Schimmer worked at PIPER SANDLER.

Josh Schimmer's average stock forecast success ratio is 56.12% with an average time for price targets to be met of 246.03 days.

Most recent stock forecast was given on BLU, at 18-Apr-2023.

Wall Street Analyst Josh Schimmer

Analyst best performing recommendations are on SPRO.
The best stock recommendation documented was for SPRO at 9/21/2022. The price target of $2 was fulfilled within 1 day with a profit of $1.18 (143.9%) receiving and performance score of 1439.02.

Average potential price target upside

of $62.54 (21.92%) on BIIB (BIOGEN).
of $62.48 (52.23%) on AMGN (AMGEN).
of $51.2 (72.88%) on GWPH.

ALXN BLU DICE FDMT HRTX Heron Therapeutics INSM Insmed IONS Ionis Pharmaceuticals MDGL Madrigal Pharmaceuticals REGN Regeneron Pharmaceuticals RGNX REGENXBIO SPRO VTYX CABA ICVX INBX Inhibrx ADMS Adamas Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Geoffrey Porges (LEERINK)